Patients with pre-existing joint conditions, obesity-related joint loading, or older age may be at greater baseline risk of musculoskeletal symptoms during treatment
PlexusDx patients bypass the entire approval process and receive medication at transparent, committed pricing
Incretin action of GIP is dramatically reduced in the presence of diabetes, as demonstrated by the evidence that glucose-dependent insulin secretion is not potentiated by GIP administration in subjects with diabetes [33, 34]
Off-label Use: Many individuals are using these drugs purely for cosmetic weight loss rather than medical necessity
Remember, GLP-1 receptor agonists are usually part of a broader treatment plan, so combining them with a balanced diet and regular exercise is essential, whether you're managing type 2 diabetes, obesity, or both